Joseph R. Stephenson Clarke

Discovery of Nanomolar-Affinity Pharmacological Chaperones Stabilizing the Oncogenic p53 Mutant Y220C

A. Joerger, M. Baud, P. Duriez, 2022, ACS pharmacology & translational science.

Key Players in the Mutant p53 Team: Small Molecules, Gene Editing, Immunotherapy

A. Rizvanov, M. Baud, E. Bulatov, 2020, Frontiers in Oncology.